|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 114 EUR | +0.13% |
|
-.--% | -.--% |
| Apr. 11 | U.S. Futures Down, European Stocks Mixed | DJ |
| Apr. 08 | DSM-Firmenich AG announces an Equity Buyback for 1,500,000 shares, representing 0.6% of its issued share capital. | CI |
AMSTERDAM (Reuters) - Dutch specialty chemicals maker DSM on Tuesday beat analyst expectations with a 13% jump in fourth-quarter core profit to 440 million euros ($497.95 million), as demand for its nutritional products remained strong despite higher prices.
Analysts in a company-compiled poll on average had predicted adjusted earnings before interest, taxes, depreciation and amortisation (EBITDA) would rise to 424 million euros, from 390 million a year before.
($1 = 0.8836 euros)
(Reporting by Bart Meijer; Editing by Himani Sarkar)
| 1st Jan change | Capi. | |
|---|---|---|
| +13.05% | 878B | |
| 0.00% | 239B | |
| +24.73% | 174B | |
| -7.11% | 127B | |
| +29.94% | 81.93B | |
| -3.89% | 75.21B | |
| -15.83% | 50.92B | |
| -22.98% | 39.43B | |
| +20.29% | 33.5B |
KONINKLIJKE DSM 
